Nephros NEPH
NASDAQ NEPH
$4.47 -0.07 (-1.59%)
At close: Sep 11, 2026 · 4:00 PM EDT

Nephros (NEPH) EBT Margin (2010 - 2026)

Nephros (NEPH) posted EBT Margin of 20.11% for Q2 2026, up 948.12% on a QoQ basis from 1.92% in Q1 2026, and up 1454.0% year-over-year from 1.29% in Q2 2025.

Analysis

Nephros (NEPH) EBT Margin (2010 - 2026) Analysis & Trends

Nephros has reported EBT Margin for 17 years, with the latest figure at 20.11% in Q2 2026.

  • On a quarterly basis, EBT Margin rose 1454.0% year-over-year to 20.11% in Q2 2026; TTM through Jun 2026 was 8.26%, a 27.0% increase from a year earlier, with the FY2025 full-year figure at 6.42%, up 579.0% from the prior year.
  • EBT Margin was 20.11% for Q2 2026 at Nephros, up from 1.92% in the prior quarter.
  • The five-year high for EBT Margin was 20.11% in Q2 2026, with the low at 71.98% in Q1 2022.
  • Average EBT Margin over 5 years is 10.25%, with a median of 5.52% recorded in 2024.
  • The sharpest annual moves came in 2022 and 2023: EBT Margin slumped 3440 bps in 2022, then surged 6400 bps in 2023.
  • Over 5 years, EBT Margin stood at 26.94% in 2022, then advanced by 5 bps to 25.63% in 2023, then surged by 137 bps to 9.41% in 2024, then tumbled by 86 bps to 1.31% in 2025, then surged by 1434 bps to 20.11% in 2026.
  • The last three EBT Margin figures came in at 20.11% (Q2 2026), 1.92% (Q1 2026), and 1.31% (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Abbott Laboratories 178.01 Bn 172.41 Bn 7.27 Bn 12.10%
2 Intuitive Surgical 131.29 Bn 126.08 Bn 1.96 Bn 36.46%
3 Medtronic 116.38 Bn 107.56 Bn 6.34 Bn 18.13%
4 Stryker 106.01 Bn 102.53 Bn 4.50 Bn 23.74%
5 Boston Scientific 63.40 Bn 62.86 Bn 3.85 Bn 19.48%
6 Edwards Lifesciences 48.89 Bn 44.64 Bn 1.35 Bn 29.86%
7 Alcon 32.59 Bn 31.13 Bn 1.68 Bn -1.65%
8 Dexcom 31.84 Bn 29.89 Bn 830.00 Mn 24.27%
9 Steris 20.61 Bn 20.13 Bn 684.20 Mn 18.32%
10 Nephros 48.31 Mn 43.62 Mn 4.03 Mn 20.11%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.11%
Mar 31, 2026 1.92%
Dec 31, 2025 1.31%
Sep 30, 2025 7.14%
Jun 30, 2025 5.57%
Mar 31, 2025 11.07%
Dec 31, 2024 9.41%
Sep 30, 2024 5.20%
Jun 30, 2024 -8.89%
Mar 31, 2024 -5.91%
Dec 31, 2023 -25.63%
Sep 30, 2023 -5.13%
Jun 30, 2023 -11.90%
Mar 31, 2023 -7.98%
Dec 31, 2022 -26.94%
Sep 30, 2022 -53.18%
Jun 30, 2022 -28.74%
Mar 31, 2022 -71.98%
Dec 31, 2021 -26.76%
Sep 30, 2021 -31.42%